SLNO Insider Trading
Insider Ownership Percentage: 12.30%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $139,065,642.37
Soleno Therapeutics Insider Trading History Chart
This chart shows the insider buying and selling history at Soleno Therapeutics by year and by quarter.
Skip ChartChart Data in Insider Trading History Table
Soleno Therapeutics Share Price & Price History
Current Price: $67.23
Price Change: ▲ Price Increase of +4.36 (6.93%)
As of 04/11/2025 05:00 PM ET
Soleno Therapeutics Insider Trading History
Soleno Therapeutics Institutional Trading History
Data available starting January 2016
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.
Read More on Soleno Therapeutics
Today's Range
Now: $67.23
52 Week Range
Now: $67.23
Volume
985,354 shs
Average Volume
707,660 shs
Market Capitalization
$3.08 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
Who are the company insiders with the largest holdings of Soleno Therapeutics?
Soleno Therapeutics' top insider shareholders include:
- Vivo Opportunity, Llc (Major Shareholder)
- Perceptive Advisors Llc (Major Shareholder)
- Bhatnagar Anish (CEO)
- James H Mackaness (CFO)
- Kristen Yen (Insider)
- Patricia C Hirano (Insider)
- Michael F Huang (VP)
- Matthew Pauls (Director)
Learn More about top insider investors at Soleno Therapeutics.
Who are the major institutional investors of Soleno Therapeutics?
Which institutional investors are buying Soleno Therapeutics stock?
During the last quarter, SLNO stock was acquired by institutional investors including:
- GAMMA Investing LLC
- Rhumbline Advisers